Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-036837
Filing Date
2015-06-12
Accepted
2015-06-12 09:00:43
Documents
13
Period of Report
2015-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q v412674_10q.htm 10-Q 276604
2 EXHIBIT 10.1 v412674_ex10-1.htm EX-10.1 382733
3 EXHIBIT 10.2 v412674_ex10-2.htm EX-10.2 166853
4 EXHIBIT 31.1 v412674_ex31-1.htm EX-31.1 10072
5 EXHIBIT 31.2 v412674_ex31-2.htm EX-31.2 10715
6 EXHIBIT 32.1 v412674_ex32-1.htm EX-32.1 4399
7 EXHIBIT 32.2 v412674_ex32-2.htm EX-32.2 4385
  Complete submission text file 0001144204-15-036837.txt   3591756

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT lltp-20150430.xml EX-101.INS 279988
9 XBRL TAXONOMY EXTENSION SCHEMA lltp-20150430.xsd EX-101.SCH 26140
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lltp-20150430_cal.xml EX-101.CAL 33119
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lltp-20150430_def.xml EX-101.DEF 116145
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE lltp-20150430_lab.xml EX-101.LAB 626528
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lltp-20150430_pre.xml EX-101.PRE 220705
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55330 | Film No.: 15927417
SIC: 1000 Metal Mining